OPKO Health, Inc. Earnings Per Share, Basic and Diluted
OPKO Health, Inc. (OPK) reported Earnings Per Share, Basic and Diluted of $0.05 per share for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-04-28.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-04-28
- OPKO Health, Inc. earnings per share, basic and diluted for the quarter ending 2021-03-31 was $0.05.
- OPKO Health, Inc. earnings per share, basic and diluted for the quarter ending 2020-12-31 was $0.05.
- OPKO Health, Inc. earnings per share, basic and diluted for the quarter ending 2020-09-30 was $0.04.
- OPKO Health, Inc. earnings per share, basic and diluted for the quarter ending 2020-06-30 was $0.05.
- OPKO Health, Inc. earnings per share, basic and diluted for fiscal 2020 was $0.05.
- OPKO Health, Inc. earnings per share, basic and diluted for fiscal 2019 was -$0.53.
- OPKO Health, Inc. earnings per share, basic and diluted for fiscal 2018 was -$0.27.
- OPKO Health, Inc. earnings per share, basic and diluted for fiscal 2017 was -$0.55.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 9 month as first filed | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|---|---|
| 2021-03-31 | $0.05 10-Q · filed 2021-04-28 | |||||
| 2020-12-31 | $0.05 10-K · filed 2021-02-18 | $0.05 10-K · filed 2021-02-18 | ||||
| 2020-09-30 | $0.04 10-K · filed 2021-02-18 | $0.00 10-Q · filed 2020-10-29 | ||||
| 2020-06-30 | $0.05 10-K · filed 2021-02-18 | -$0.04 10-Q · filed 2020-07-31 | ||||
| 2020-03-31 | -$0.09 10-Q · filed 2021-04-28 | |||||
| 2019-12-31 | -$0.18 10-K · filed 2021-02-18 | -$0.53 10-K · filed 2021-02-18 | ||||
| 2019-09-30 | -$0.11 10-K · filed 2021-02-18 | -$0.35 10-Q · filed 2020-10-29 | ||||
| 2019-06-30 | -$0.10 10-K · filed 2021-02-18 | -$0.24 10-Q · filed 2020-07-31 | ||||
| 2019-03-31 | -$0.14 10-K · filed 2021-02-18 | |||||
| 2018-12-31 | -$0.13 10-K · filed 2020-03-02 | -$0.27 10-K · filed 2021-02-18 | ||||
| 2018-09-30 | -$0.05 10-K · filed 2020-03-02 | -$0.14 10-Q · filed 2019-11-05 | ||||
| 2018-06-30 | -$0.01 10-K · filed 2020-03-02 | -$0.09 10-Q · filed 2019-08-07 | ||||
| 2018-03-31 | -$0.08 10-K · filed 2020-03-02 | |||||
| 2017-12-31 | -$0.39 derived: net income ÷ weighted average shares · filed 2020-03-02 | -$0.45 derived: net income ÷ weighted average shares · filed 2020-03-02 | -$0.55 10-K · filed 2018-03-01 | |||
| 2017-09-30 | -$0.06 10-Q · filed 2018-11-09 | -$0.08 10-Q · filed 2017-11-08 | -$0.16 10-Q · filed 2018-11-09 | -$0.17 10-Q · filed 2017-11-08 | ||
| 2017-03-31 | -$0.06 10-Q · filed 2018-05-08 | -$0.10 derived: net income ÷ weighted average shares · filed 2019-01-29 | -$0.14 derived: net income ÷ weighted average shares · filed 2019-01-29 | |||
| 2016-12-31 | -$0.04 derived: net income ÷ weighted average shares · filed 2019-01-29 | -$0.08 derived: net income ÷ weighted average shares · filed 2019-01-29 | -$0.05 10-K · filed 2018-03-01 | |||
| 2016-09-30 | -$0.03 10-Q · filed 2017-11-08 | -$0.02 10-Q · filed 2017-11-08 | ||||
| 2016-03-31 | -$0.02 10-Q · filed 2017-05-10 | |||||
| 2015-12-31 | -$0.06 10-K · filed 2018-03-01 | |||||
| 2015-06-30 | -$0.09 10-Q · filed 2015-08-05 | -$0.35 10-Q · filed 2015-08-05 | -$0.48 derived: net income ÷ weighted average shares · filed 2017-03-01 | -$0.59 derived: net income ÷ weighted average shares · filed 2017-03-01 | ||
| 2015-03-31 | -$0.26 10-Q · filed 2016-05-09 | -$0.39 derived: net income ÷ weighted average shares · filed 2017-03-01 | -$0.50 derived: net income ÷ weighted average shares · filed 2017-03-01 | -$0.57 derived: net income ÷ weighted average shares · filed 2017-03-01 | ||
| 2014-12-31 | -$0.12 10-K · filed 2015-02-27 | -$0.24 derived: net income ÷ weighted average shares · filed 2017-03-01 | -$0.30 derived: net income ÷ weighted average shares · filed 2017-03-01 | -$0.41 10-K · filed 2017-03-01 | ||
| 2014-09-30 | -$0.11 10-K · filed 2015-02-27 | -$0.18 derived: net income ÷ weighted average shares · filed 2016-02-29 | -$0.28 10-Q · filed 2014-11-07 | -$0.33 derived: net income ÷ weighted average shares · filed 2016-02-29 | ||
| 2014-06-30 | -$0.06 10-Q · filed 2015-08-05 | -$0.17 10-Q · filed 2015-08-05 | -$0.21 derived: net income ÷ weighted average shares · filed 2016-02-29 | -$0.37 derived: net income ÷ weighted average shares · filed 2016-02-29 | ||
| 2014-03-31 | -$0.11 10-Q · filed 2015-05-11 | -$0.15 derived: net income ÷ weighted average shares · filed 2016-02-29 | -$0.31 derived: net income ÷ weighted average shares · filed 2016-02-29 | -$0.33 derived: net income ÷ weighted average shares · filed 2016-02-29 | ||
| 2013-12-31 | -$0.04 10-K · filed 2015-02-27 | -$0.20 derived: net income ÷ weighted average shares · filed 2016-02-29 | -$0.22 derived: net income ÷ weighted average shares · filed 2016-02-29 | -$0.32 10-K · filed 2016-02-29 | ||
| 2013-09-30 | -$0.17 10-K · filed 2015-02-27 | -$0.18 derived: net income ÷ weighted average shares · filed 2015-02-27 | -$0.29 10-Q · filed 2014-11-07 | -$0.31 derived: net income ÷ weighted average shares · filed 2015-02-27 | ||
| 2013-06-30 | -$0.01 10-K · filed 2015-02-27 | -$0.12 10-Q · filed 2014-08-11 | -$0.12 derived: net income ÷ weighted average shares · filed 2015-02-27 | -$0.16 derived: net income ÷ weighted average shares · filed 2015-02-27 | ||
| 2013-03-31 | -$0.11 10-K · filed 2015-02-27 | -$0.12 derived: net income ÷ weighted average shares · filed 2015-02-27 | -$0.15 derived: net income ÷ weighted average shares · filed 2015-02-27 | |||
| 2012-12-31 | $0.00 10-K · filed 2013-03-18 | -$0.04 derived: net income ÷ weighted average shares · filed 2015-02-27 | -$0.11 10-K · filed 2015-02-27 | |||
| 2012-09-30 | -$0.03 10-Q · filed 2013-11-12 | -$0.10 10-Q · filed 2013-11-12 | ||||
| 2012-06-30 | -$0.04 10-Q · filed 2013-08-09 | -$0.07 10-Q · filed 2013-08-09 | ||||
| 2012-03-31 | -$0.03 10-Q · filed 2013-05-10 | |||||
| 2011-12-31 | -$0.01 10-K · filed 2014-03-03 | |||||
| 2011-09-30 | -$0.03 10-Q · filed 2012-11-09 | -$0.08 10-Q · filed 2012-11-09 | ||||
| 2011-06-30 | -$0.02 10-Q · filed 2012-08-09 | -$0.05 10-Q · filed 2012-08-09 | ||||
| 2010-12-31 | -$0.08 10-K · filed 2013-03-18 | |||||
| 2010-09-30 | -$0.03 10-Q · filed 2011-11-09 | -$0.08 10-Q · filed 2011-11-09 | ||||
| 2010-06-30 | -$0.03 10-Q · filed 2011-08-08 | -$0.05 10-Q · filed 2011-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |